Anti-atherosclerotic activity of root bark of Premna integrifolia Linn. in high fat diet induced ath

来源 :Journal of Pharmaceutical Analysis | 被引量 : 0次 | 上传用户:sunshinewlm
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Premna integrifolia Linn. is a medicinal plant used in “Dhasamula” drug preparation of Ayurvedic systems of medicine in the treatment of various ailments like bronchitis, dyspepsia, liver disorders, piles, constipation,hyperlipidemia and fever. The anti-atherosclerotic activity of hydroalcoholic extract(HAE) of root bark of P.integrifolia was evaluated in high fat diet induced atherosclerosis rats. Sixty Wistar rats were divided into six groups: the first group served as control, the second group was fed with high fat diet and the other three groups were fed with high fat diet along with various concentrations of HAE and the last group was treated with atorvastatin for 30 days. Lipid and lipoprotein profile, atherogenic index, and cardiac markers and histopathological evaluation of aorta were determined in high fat diet induced atherosclerosis rats. HAE of P.integrifolia produced a significant and dose-dependent anti-atherosclerotic activity in terms of reduction in lipids and lipoprotein profile, atherogenic index, HMG-Co A reductase activity, marker enzymes such as lactate dehydrogenase(LDH), creatine phosphokinase(CPK), aspartate transaminase(AST), alanine transaminase(ALT) and alkaline phosphatase(ALP), alteration in collagen and calcium contents, mild mineralization and focal rupture of intima and media of aorta was noticed in treated groups as compared to the control. The results suggested that anti-atherosclerotic activity of HAE of P. integrifolia Linn. was due to its modulatory activity on metabolic pathway of lipid. The results contribute to the validation of the traditional use of Agnimantha in high fat diet induced atherosclerosis rats. Premna integrifolia Linn. Is a medicinal plant used in “Dhasamula” drug preparation of Ayurvedic systems of medicine in the treatment of various ailments like bronchitis, dyspepsia, liver disorders, piles, constipation, hyperlipidemia and fever. The anti-atherosclerotic activity of hydroharmaceutical extract (HAE) of root bark of P. integrifolia was evaluated in high fat diet induced atherosclerosis rats. Sixty Wistar rats were divided into six groups: the first group served as control, the second group was fed with high fat diet and the other three groups were fed with high fat diet along with various concentrations of HAE and the last group was treated with atorvastatin for 30 days. rats. HAE of P. integrifolia produced a significant and dose-dependent anti-atherosclerotic activity in terms of reduction in lipids and lipopr otein profile, atherogenic index, HMG-Co A reductase activity, marker enzymes such as lactate dehydrogenase (LDH), creatine phosphokinase (CPK), aspartate transaminase (AST), alanine transaminase (ALT) and alkaline phosphatase and calcium contents, mild mineralization and focal rupture of intima and media of aorta was noticed in treated groups as compared to the control. The results suggested that anti-atherosclerotic activity of HAE of P. integrifolia Linn. was due to its modulatory activity on metabolic pathway of lipid. The results contribute to the validation of the traditional use of Agnimantha in high fat diet induced atherosclerosis rats.
其他文献
目的探讨剖腹引流术治疗重症急性胰腺炎包裹性坏死病灶(WOPN)的效果。方法回顾性分析2005年1月至2016年10月新疆医科大学第一附属医院收治的154例WOPN患者的临床资料,其中2005年1月至2012年10月收治的83例患者采用传统剖腹清创灌洗术(清创组),2012年11月至2016年10月收治的71例患者采用腹部小切口入路低位置管引流术(引流组),分析并比较两种方法的临床疗效。结果清创组4
1例56岁男性心力衰竭伴心房颤动、甲状腺功能亢进患者因慢性心力衰竭急性发作入院,入院时心室率186次/min,给予胺碘酮(负荷量150 mg静脉注射,维持量300 mg静脉滴注)控制心室率。当晚再次静脉泵入胺碘酮300 mg。次日,患者出现意识不清,心电监护示心率92次/min,QT间期平均0.40 s,频发室性早搏,心室率256次/min,尖端扭转型室性心动过速及心室颤动交替出现。紧急予心脏捶击
目的 探讨老年人急性左心衰预防与治疗的临床措施等.方法 选自2015年4月~2018年10月我方医院收治的106例急性左心衰患者.采用随机数字表法均分为两组.对照组53例患者采取常规
目的:研究分析临床中对于严重创伤患者的急诊急救护理过程,并探讨护理过程中存在的问题以及解决方案,以便严重创伤患者能够快速的救治,方便患者的临床治疗.方法:选取我院急诊
期刊
目的分析变性近视后巩膜加固术随访5年的效果。方法回顾性分析研究。随机分为两组,变性近视行后巩膜加固术的37例(48眼),为手术组;未行手术只愿定期随访的32例(48眼),为对照组。两组均连续观察5年。结果两组之间基线资料差异无统计学意义。5年随访结束后,手术组平均眼轴长度为(29.81±1.28)mm,短于对照组的(30.93±1.33)mm(t=-3.269,P=0.002)。手术组的平均屈光度
2例女性患者(年龄分别为42和33岁)分别因子宫腺肌症和子宫肌瘤入院手术治疗,均无肾病史,分别于第2和第4次静脉滴注阿莫西林克拉维酸钾2.4 g后出现恶心、呕吐、血尿、尿量减少、轻度水肿等症状,实验室检查示Scr和BUN异常(例1: Scr 423 μmol/L,BUN 7.2 mmol/L;例2:Scr 443 μmol/L,BUN 6.8 mmol/L)。2例患者均立即停用阿莫西林克拉维酸钾,
目的探讨术中胰腺残端的淀粉酶测定值对术后胰瘘的预测价值。方法收集2017年6月至2018年7月上海瑞金医院收治的26例行胰体尾切除术及胰中段切除术患者的临床资料,对术中胰腺残端的淀粉酶水平及围手术期可能与胰瘘发生有关的临床因素进行分析。应用受试者工作特征(ROC)曲线评估术中胰腺残端淀粉酶水平预测患者术后发生胰瘘的诊断效能,计算敏感度和特异度。结果26例患者中19例行胰体尾切除术,7例行胰中段切除
目的探讨血清中各项前列腺特异性抗原(PSA)[游离PSA(fPSA)、总PSA(tPSA)、前列腺特异性抗原比值(fPSA/tPSA)]联合磁共振弥散加权中表观扩散系数(ADC)及波谱成像在tPSA 4~10 μg/L前列腺癌(PSA灰区前列腺癌,PCa)的诊断价值。方法选取2013年12月至2015年2月诊治的血清tPSA值为4~10 μg/L的老年患者56例,其中26例为PCa,30例为前列腺